69 related articles for article (PubMed ID: 4000099)
1. [Studies on sensitivity test with clonogenic assay against chemo-endocrine therapy for human breast cancer].
Hamada Y
Nihon Geka Gakkai Zasshi; 1985 Apr; 86(4):411-23. PubMed ID: 4000099
[TBL] [Abstract][Full Text] [Related]
2. [Human tumor clonogenic assay in human breast cancer].
Kobayashi T; Kuraishi Y; Aiba K; Inoue K
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1566-72. PubMed ID: 3927846
[TBL] [Abstract][Full Text] [Related]
3. Hormone dependency of human breast neoplasms cultured in vitro in the stem cell assay.
Manni A; Wright C; Pontari M; Feil P; Joehl R
J Natl Cancer Inst; 1985 Apr; 74(4):767-70. PubMed ID: 2985856
[TBL] [Abstract][Full Text] [Related]
4. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
5. [Hormone-dependency of human breast cancer in in vitro clonogenic assay].
Nomura Y; Tashiro H; Takaekoh F; Hisamatsu K
Gan No Rinsho; 1987 Feb; 33(2):153-8. PubMed ID: 3560449
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy testing for human ovarian cancer using in vitro colony assay].
Inoue K
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1593-8. PubMed ID: 2411225
[TBL] [Abstract][Full Text] [Related]
7. Drug and hormone sensitivity of estrogen receptor-positive and -negative human breast cancer cells in vitro.
Goldenberg GJ; Froese EK
Cancer Res; 1982 Dec; 42(12):5147-51. PubMed ID: 7139616
[TBL] [Abstract][Full Text] [Related]
8. In vitro clonogenic growth and metastatic potential of human operable breast cancer.
Nomura Y; Tashiro H; Hisamatsu K
Cancer Res; 1989 Oct; 49(19):5288-93. PubMed ID: 2766296
[TBL] [Abstract][Full Text] [Related]
9. Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay.
Osborne CK; Von Hoff DD; Mullins K
Breast Cancer Res Treat; 1985; 6(3):229-35. PubMed ID: 2936413
[TBL] [Abstract][Full Text] [Related]
10. A possible direct action of a gonadotropin-releasing hormone agonist, goserelin, on the clonogenic growth of human breast cancer.
Nomura Y; Tashiro H; Hisamatsu K
Anticancer Res; 1993; 13(5A):1443-5. PubMed ID: 8239517
[TBL] [Abstract][Full Text] [Related]
11. Influence of tamoxifen and estradiol on the growth of human breast cancer cells in vitro.
Arafah BM; Griffin P; Gordon NH; Pearson OH
Cancer Res; 1986 Jul; 46(7):3268-72. PubMed ID: 3708561
[TBL] [Abstract][Full Text] [Related]
12. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
13. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibitory effect of estrogen conjugated drugs against primary cultured breast cancer cells.
Matsuoka H; Sugimachi K; Tomoda H; Saito T; Seo Y
Anticancer Res; 1995; 15(4):1289-96. PubMed ID: 7654011
[TBL] [Abstract][Full Text] [Related]
15. Different chemo- and endocrino-sensitivity of MCF-7 cells with or without estradiol supplement in vitro.
Tanino H; Kubota T; Saikawa Y; Kuo TH; Takeuchi T; Kase S; Furukawa T; Kitajima M; Sakurai T; Naito Y
Anticancer Res; 1993; 13(4):1219-21. PubMed ID: 8352547
[TBL] [Abstract][Full Text] [Related]
16. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
Chen J; Power KA; Mann J; Cheng A; Thompson LU
Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
[TBL] [Abstract][Full Text] [Related]
18. [Influence of endocrine therapy on the proliferation of estrogen (ER) positive cells and ER negative cells of human breast cancer (MCF-7)].
Noguchi M; Tajiri K; Taniya T; Kumaki T; Miyazaki I
Nihon Geka Gakkai Zasshi; 1989 May; 90(5):780-5. PubMed ID: 2529423
[TBL] [Abstract][Full Text] [Related]
19. [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].
Bachmann-Moisson N; Barberi-Heyob M; Merlin JL; Ledrich ML; Batt AM; Guillemin F
Bull Cancer; 1996 Oct; 83(10):808-15. PubMed ID: 8952630
[TBL] [Abstract][Full Text] [Related]
20. A possible regulatory role of 17beta-estradiol and tamoxifen on glyoxalase I and glyoxalase II genes expression in MCF7 and BT20 human breast cancer cells.
Rulli A; Antognelli C; Prezzi E; Baldracchini F; Piva F; Giovannini E; Talesa V
Breast Cancer Res Treat; 2006 Mar; 96(2):187-96. PubMed ID: 16319983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]